David Klonoff, MD
David C. Klonoff, M.D. is an endocrinologist specializing in the development and use of diabetes technology. He is Medical Director of the Dorothy L. and James E. Frank Diabetes Research Institute of Mills-Peninsula Medical Center in San Mateo, California and a Clinical Professor of Medicine at UCSF. Dr. Klonoff received an FDA Director’s Special Citation Award in 2010 for outstanding contributions related to diabetes technology. In 2012, Dr. Klonoff was elected as a Fellow of the American Institute of Medical and Biological Engineering (AIMBE) and cited as one of the 1000 top bioengineers in the world, as well as among the top 2% of the world’s bioengineers for his engineering work in diabetes technology. He received the 2012 Gold Medal Oration and Distinguished Scientist Award from the Dr. Mohan’s Diabetes Specialities Centre and Madras Diabetes Research Foundation of Chennai, India. Dr. Klonoff was invited to speak to the US Congressional Diabetes Caucus in 2017, participate in the White House Health and Cybersecurity Roundtable in 2015, and speak at the European Parliament in 2010. He is the Founding Editor-in-Chief of Journal of Diabetes Science and Technology. He has authored over 270 publications. Dr. Klonoff has been a Principal Investigator on 110 clinical trials of diabetes drugs and devices. He was the lead investigator for the first randomized controlled multicenter trial of an outpatient artificial pancreas product, and published the results in the New England Journal of Medicine. He chaired the scientific advisory board for the first FDA-cleared insulin patch pump and participated in developing the first FDA-cleared dedicated diabetes telemedicine system. Dr. Klonoff coined the term “diabetes technology” and founded the Diabetes Technology Meeting, the Digital Diabetes Congress, and the Medical Device Security and Privacy Meeting. Dr. Klonoff has chaired or served on 52 grant review panels, including, for the US, NIH, CDC, NASA, NSF, US Army, NOAA, ADA, and JDRF; plus agencies in 7 foreign countries. He is a member of the Scientific Advisory Board of the TexasA&M/UCLA/FIU/Rice PATHS-UP Engineering Research Center and an affiliate member of the Baylor University Center for Space Medicine. Dr. Klonoff is a graduate of UC Berkeley, where he was elected to Phi Beta Kappa in his junior year, and UCSF Medical School, where he was elected to Alpha Omega Alpha in his junior year. His postgraduate training included two years at UCLA Hospital and three years at UCSF Hospitals. He is a member of the Healthcare Sector Coordinating Council Joint Cyber Working Group for Medical Devices/Healthcare. He chaired DTSec and DTMoSt, the world’s 1st and 2nd consensus medical device cybersecurity standards.